A Review on Pathological High-risk Factors and Postoperative Adjuvant Chemotherapy in Stage IA Lung Adenocarcinoma
This article is a review on the research progress of the above pathological high-risk factors and the role of adjuvant chemotherapy in patients with pathological high-risk factors in stage IA lung adenocarcinoma.
DOI: 10.3779/j.issn.1009-3419.2022.101.30
Source: Chinese Journal of Lung Cancer - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | China Health | Lung Cancer | Micropapillary Carcinoma | Non-Small Cell Lung Cancer